Overcoming the skin barrier with artificial smart carriers of drugs
G. Cevc
Medical Biophysics Klinikum r.d.I., Ismaningerstr. 22,
The Technical University of Munich, D-81675 Munich, E.U.
In: Intelligent Materials: Novel Concepts for Controlled
Release Technologies. (S. Dinh and J. DeNuzzio, eds.) ACS Books, Washington,
DC, 1999.
Special intercellular lipidic seals and the tight packing
of cells in the skin prevent molecules greater than a few hundred Dalton
to cross the organ. Electrical (iontophoresis) or mechanical (ultrasonication)
methods generate too few passages in the barrier to overcome the obstacle
and to deliver large molecules across the skin. Such goal is achieved
by suitable composite, 'intelligent' aggregates that exert directed pressure
on the intercellular junctions in the skin; this opens numerous hydrophilic
channels through the stratum corneum, typically between the cell envelope
and the skin sealing lipid multi-layers. The common characteristics of
such aggregates, Transfersomes ('carrying bodies'), are the non-uniform
and high aggregate deformability (mechano-sensitivity) and the high responsiveness
to external transcutaneous gradient(s) (e.g. hydro-sensitivity). Mechano-sensitivity
is reflected in the strongly non-linear Transfersome reaction to ambient
stress; hydrosensitivity is seen from the very strong Transfersome tendency
to bind water. Combination of both properties enables Transfersomes to
move through the skin and carry pharmacological agents, including polypeptides,
across the intact permeability barrier after non-occlusive administration.
Aggregates without the described characteristics, such as conventional
liposomes or mixed lipid micelles, remain confined to the skin surface.
The results of in vivo experiments with corticosteroids (hydrocortisone,
dexamethasone, triamcinolone), non-steroidal anti-inflammatory agents
(diclofenac), and proteins (calcitonin, insulin, serum albumin) in Transfersomes
illustrate the main advantages of 'smart carriers': the respective main
achievements are drug targeting into the skin (> 99.9%), the improvement
of regional/systemic drug concentration ratio (10 x ), and the high efficiency
of non-invasive macromolecular delivery (> 50%). In every case, the duration
of biological action is prolonged.
<---- |
Home |
About us |
Corporate Factsheet |
Science |
Publications |
Product opportunities |
Finance |
Press releases |
Latest newsletter |
Press clippings |
Conferences |
Career |
Contact |
Scientific FAQ |
Glossary |
Site Map |
Search |